A dispensary in the Hudson Valley is offering patients a new form of medical marijuana — the first raw cannabis product to be offered in New York.
Dr. Stacia Woodcock is assistant director of operations at Curaleaf New York.
“This is the first actual flower-based medical cannabis product available in New York. So we’re the first dispensary that’s been able to bring this to market,” Woodcock says. “And that’s important for a couple of reasons. One is that it’s cannabis in its most natural form, so minimal processing. All of the terpenes and cannabinoids are still intact. It’s the actual plant material, but it’s still processed in a way so it’s free of any pesticides or contaminants, so it’s safe for the patient.”
The ground flower pods were first sold in Curaleaf’s Long Island dispensary, and are now available at the Newburgh location. Woodcock says the ground flower is cost effective.
“So when we look at the ground flower, patients are receiving 700 milligrams of active cannabinoids for a cost of $55. And so that’s almost double the amount the cannabinoids they would be able to get from an average vape pen that would cost anywhere from $55-$80, depending on what percentage it is,” says Woodcock. [Read more at WAMC]
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers